nach oben

memo - Magazine of European Medical Oncology

Tipp

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer with peritoneal metastasis: Status quo and how should we proceed

verfasst von: Prim. Prof. Dr. Ingmar Königsrainer

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Excerpt

Metastatic disease in colorectal cancer (CRC) is a challenging multidisciplinary disease, nowadays, embracing all oncological disciplines. …

Vorheriger Artikel Fertility preservation

Nächster Artikel Molecular profiling—ready for clinical routine

Quenet F, Elias D, Roca L, Goere D, Ghouti L, Pocard M, et al. A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. J Clin Oncol. 2018; https://doi.org/10.1200/JCO.2018.36.18_SUPPL.LBA3503. CrossRef

Maggiori L, Goéré D, Viana B, Tzanis D, Dumont F, Honoré Ch, et al. Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case-control study. Ann Surg. 2013;258(1):116–21. CrossRef

Horvarth P, Königsrainer I. Patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal cancer. memo. 2020;13(4). https://doi.org/10.1007/s12254-020-00633-w. CrossRef

Gasser E, Kogler P, Lorenz A, Kafka-Ritsch R, Öfner D, Perathoner A. Do we still need CRS and HIPEC in colorectal cancer in times of modern chemotherapy and immunotherapy? memo. 2020;13(4) https://doi.org/10.1007/s12254-020-00647-4. CrossRef

Yurttas C, Fisher OM, Cortés-Guiral D, Haen SP, Königsrainer IA, Beckert S, Liauw W,·Löffer MW. Cytoreductive surgery and HIPEC in colorectal cancer—did we get hold of the wrong end of the stick? memo 2020;13(4). https://doi.org/10.1007/s12254-020-00653-6. CrossRef

Titel: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer with peritoneal metastasis: Status quo and how should we proceed
verfasst von: Prim. Prof. Dr. Ingmar Königsrainer
Publikationsdatum: 01.12.2020
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 4/2020
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-020-00655-4

Springer Medizin Österreich

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer with peritoneal metastasis: Status quo and how should we proceed

Excerpt

Springer Medizin Österreich

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2020

Molecular profiling in breast cancer—ready for clinical routine?

A case report on the long-term survival of a patient with HER2-positive metastatic gastric adenocarcinoma and a short review of the current literature

Homologous recombination deficiency in breast cancer

Molecular profiling—ready for clinical routine

Fertility preservation in women with endometrial cancer

Tackling DNA damage repair mechanisms—a promising molecular informed therapeutic approach in pancreatic ductal adenocarcinoma